Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive (Q41156): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Transtornos do espectro associado ao anticorpo anti-MOG são doenças inflamatórias desmielinizantes do sistema nervoso central com predileção pelo nervo óptico que incluem um subgrupo de pacientes com neurite óptica (NO) bilateral, mielite longitudinal extensa (> 3 segmentos vertebrais) (frequentemente recorrente) e raramente pacientes com apresentação de NMO-like, O fenótipo clínico e imunopatológico está sob investigação ativa. | |||||||||||||||
| description / en | description / en | ||||||||||||||
MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/605048789 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:8A41.1 | |||||||||||||||
| Property / CURIE: CID11:8A41.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-8A41.1 | |||||||||||||||
| Property / Canary Token: dki-india-8A41.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: G35-G37 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 07:13, 13 August 2026
MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 8A41.1 |
||
| English | Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive |
MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation |
Statements
CID11:8A41.1
0 references
dki-india-8A41.1
0 references
Concluído
0 references
13 August 2026
0 references
